HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emma Gostick Selected Research

HLA-A*02:01 antigen

10/2012T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.
1/2012Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.
10/2009Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.
3/2009High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow.
9/2007Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.
7/2007The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor.
12/2005T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization.
4/2004Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emma Gostick Research Topics

Disease

18Infections
10/2020 - 06/2007
14Neoplasms (Cancer)
01/2022 - 07/2007
7Leukemia
01/2018 - 10/2003
6Wilms Tumor (Wilm's Tumor)
10/2017 - 12/2005
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 10/2003
4Persistent Infection
01/2019 - 11/2005
4Virus Diseases (Viral Diseases)
05/2015 - 06/2008
4Melanoma (Melanoma, Malignant)
04/2014 - 09/2007
3HIV Infections (HIV Infection)
05/2015 - 01/2012
3Human Influenza (Influenza)
01/2013 - 01/2012
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2008 - 12/2005
2Viremia
12/2020 - 11/2007
2Bites and Stings (Sting)
01/2019 - 03/2015
2Tuberculosis (Tuberculoses)
03/2015 - 06/2010
2Malaria
03/2015 - 02/2013
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2015 - 01/2012
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2010 - 12/2005
2Myeloid Leukemia (Leukemia, Myelocytic)
03/2009 - 04/2004
1Cicatrix (Scar)
01/2021
1Infectious Mononucleosis (Glandular Fever)
12/2020
1Lymphoma (Lymphomas)
12/2020
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
12/2020
1Chronic Hepatitis B
10/2020
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2020
1Ankylosing Spondylitis
01/2019
1Needlestick Injuries (Needlestick Injury)
01/2019
1Large Granular Lymphocytic Leukemia
01/2018
1Neutropenia
01/2018
1Rheumatoid Arthritis
01/2018
1Hypersensitivity (Allergy)
10/2017
1Hepatocellular Carcinoma (Hepatoma)
04/2014
1Respiratory Syncytial Virus Infections
12/2011
1Epstein-Barr Virus Infections
11/2010
1Cytomegalovirus Infections (Inclusion Disease)
09/2010
1Pathologic Complete Response
08/2010
1Acquired Immunodeficiency Syndrome (AIDS)
10/2008
1Necrosis
04/2008
1Autoimmune Diseases (Autoimmune Disease)
04/2008

Drug/Important Bio-Agent (IBA)

22AntigensIBA
01/2021 - 10/2003
17EpitopesIBA
01/2020 - 01/2005
13Peptides (Polypeptides)IBA
01/2019 - 04/2004
8VaccinesIBA
01/2022 - 06/2007
8HLA-A*02:01 antigenIBA
10/2012 - 04/2004
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 10/2009
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2012 - 07/2007
5Proteins (Proteins, Gene)FDA Link
04/2014 - 11/2005
4LigandsIBA
12/2020 - 08/2007
4Antiviral Agents (Antivirals)IBA
01/2020 - 10/2006
4WT1 ProteinsIBA
08/2015 - 12/2005
4Indicators and Reagents (Reagents)IBA
06/2012 - 07/2007
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2019 - 12/2011
3InterferonsIBA
01/2019 - 04/2014
2HLA-A Antigens (HLA-A)IBA
10/2020 - 09/2011
2HLA-B Antigens (HLA-B)IBA
01/2019 - 01/2012
2Pharmaceutical PreparationsIBA
01/2018 - 04/2008
2Dasatinib (BMS 354825)FDA Link
01/2018 - 04/2008
2Messenger RNA (mRNA)IBA
10/2017 - 12/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2017 - 04/2008
2AutoantigensIBA
03/2015 - 09/2007
2Histocompatibility Antigens Class IIBA
11/2012 - 12/2011
2CytokinesIBA
04/2008 - 08/2007
1LipidsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
10/2020
1Pattern Recognition ReceptorsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2019
1AminopeptidasesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1HLA-Bw4 antigenIBA
05/2015
1KIR ReceptorsIBA
05/2015
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2014
1GlypicansIBA
04/2014
1Herpes Zoster VaccineIBA
06/2013
1Synthetic Vaccines (Recombinant Vaccines)IBA
03/2013
1Immunoglobulin FragmentsIBA
06/2012
1Hemagglutinins (Hemagglutinin)IBA
02/2012
1Glucose (Dextrose)FDA LinkGeneric
01/2012
1preproinsulinIBA
01/2012
1Aurora Kinase AIBA
01/2012
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2012
1HLA-B57 antigenIBA
12/2011
1TCF Transcription FactorsIBA
12/2011
1Dihydrotachysterol (AT 10)IBA
12/2011
1Interleukin-10 (Interleukin 10)IBA
09/2010
1Tumor Biomarkers (Tumor Markers)IBA
08/2010
1Neoplasm Antigens (Tumor Antigens)IBA
08/2010
1Biological ProductsIBA
04/2009
1EnzymesIBA
01/2009
1SolutionsIBA
10/2008
1src-Family KinasesIBA
04/2008
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
04/2008
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2008
1Interleukin-2 (IL2)IBA
04/2008
1HLA-B27 Antigen (HLA B27 Antigen)IBA
11/2007
1MART-1 AntigenIBA
09/2007

Therapy/Procedure

6Immunotherapy
08/2015 - 12/2005
3Therapeutics
01/2022 - 01/2017
2Hematopoietic Stem Cell Transplantation
12/2020 - 03/2009
2Stem Cell Transplantation
09/2007 - 10/2003
1Transplantation
04/2008